Paul Averback - CEO, Nymox Pharmaceutical Corp

As of November 6, 2018


Paul Averback Net Worth

  • Net worth is estimated to be at least $55.49M
  • Owns at least 23,331,448 units of Nymox Pharmaceutical Corp stock
  • Sold an estimated value of $4.39M recently at Nymox Pharmaceutical Corp

Paul Averback Trading

  • Largest sale of shares was 1,687,600 units , worth over $4.22M on November 6, 2018
  • In total has made about 2 transactions recently
  • Usually trades in November, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Paul Averback Mailing Address

  • Mailing address is C/o Nymox Pharmaceutical Corporation 9900 Cavendish Blvd., Suite 306 St. Laurent A8 H4M 2V2 Quebec, Canada

Nymox Pharmaceutical Corp Insider Trading

  • The most recent transaction was 40,000 units bought on April 27, 2021 by James G Robinson worth over $83.27K
  • In the last 6 years, insiders at Nymox Pharmaceutical Corp sold an estimated value of $4.39M and bought an estimated value of $3.95M
  • The most active traders are James G Robinson, Director,  Erick Danielsen, CFO,  and Paul Averback, CEO
  • Insider trading is most common in June, with the busiest year in 2018

NYMOX PHARMACEUTICAL CORP Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1